Application Note: The Recovery of Cryopreserved H9 hESCs on the Corning® Synthemax™ Surface in Defined Medium
29 November 2011
The objective of the study in this application note was to examine the recovery of cryopreserved hESCs on a fully synthetic, xeno-free, ready to use surface, in defined medium. Scalable, reproducible, low cost and regulatory-friendly technologies such as the Corning Synthemax Surface enable clinical use of hESC-based therapeutics.